ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,578Medicare Part D Prescriptions Filled, Including Refills

Rank: 68 out of 2094

$1.1M Total Retail Price of All Prescriptions

Rank: 71 out of 2094

364 Patients Receiving at Least One Drug in Part D
77%Patients 65 Years and Older
92% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Jersey
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 364 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

5% of this provider’s 364 patients filled at least one prescription for a schedule three drug, compared to an average of 3%.

Risky Drugs to Seniors

1% of this provider’s 12,330 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

45% of this provider’s prescriptions were for brand-name drugs, compared to an average of 32%.

Prescription Price

$75 was the average price of a prescription from this provider, compared to $78 among peers.

Prescriptions per Patient

40 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Jersey
AMLODIPINE BESYLATE 654 593 1 2
OMEPRAZOLE 503 409 2 4
SIMVASTATIN 485 393 3 1
ATORVASTATIN CALCIUM 480 388 4 5
LEVOTHYROXINE SODIUM 378 364 5 3
METOPROLOL SUCCINATE 338 305 6 9
DIOVAN 324 260 7 13
DIOVAN HCT 286 228 8 28
CRESTOR 274 248 9 15
NEXIUM 268 227 10 16
LOVAZA 244 189 11 53
ZOLPIDEM TARTRATE 227 180 12 14
DONEPEZIL HCL 227 227 12 20
ALENDRONATE SODIUM 223 218 14 30
METFORMIN HCL 223 183 14 8
LOSARTAN POTASSIUM 222 183 16 17
CLOPIDOGREL 222 188 16 22
JANUVIA 218 180 18 35
METFORMIN HCL ER 210 182 19 67
NAMENDA 207 207 20 32
JANUMET 199 170 21 86
FUROSEMIDE 186 149 22 6
PROAIR HFA 179 139 23 45
HYDROCHLOROTHIAZIDE 177 142 24 12
ADVAIR DISKUS 175 149 25 36
GLIMEPIRIDE 164 125 26 31
IBANDRONATE SODIUM 162 132 27 140
TAMSULOSIN HCL 161 153 28 29
CARVEDILOL 160 150 29 19
SERTRALINE HCL 146 112 30 26
LISINOPRIL 144 125 31 7
LISINOPRIL-HYDROCHLOROTHIAZIDE 144 118 31 55
PLAVIX 141 120 33 38
VOLTAREN 131 120 34 109
TRAMADOL HCL 128 109 35 33
LIPITOR 122 114 36 39
FENOFIBRATE 117 77 37 104
SINGULAIR 117 94 37 64
GABAPENTIN 109 83 39 23
LOSARTAN-HYDROCHLOROTHIAZIDE 95 81 40 52
MELOXICAM 93 85 41 49
POTASSIUM CHLORIDE 89 74 42 24
EXFORGE 88 74 43 105
ZETIA 87 71 44 79
ACTOS 86 75 45 112
ESCITALOPRAM OXALATE 81 74 46 46
AZITHROMYCIN 79 65 47 27
MECLIZINE HCL 79 73 47 103
POLYETHYLENE GLYCOL 3350 78 76 49 75
ISOSORBIDE MONONITRATE ER 78 78 49 57
EXELON 76 76 51 111
TRICOR 76 73 51 99
LYRICA 74 45 53 85
MONTELUKAST SODIUM 73 56 54 128
LANTUS SOLOSTAR 73 49 54 76
WELCHOL 72 58 56 146
FLUTICASONE PROPIONATE 71 61 57 41
LIDODERM 69 49 58 59
METOPROLOL TARTRATE 69 55 58 10
BONIVA 61 60 60 256
WARFARIN SODIUM 60 57 61 11
DEXILANT 59 53 62 124
ENALAPRIL MALEATE 58 46 63 25
BENICAR 57 55 64 108
SPIRIVA 55 40 65 60
CELEBREX 55 46 65 74
DOXAZOSIN MESYLATE 54 54 67 120
NAPROXEN 52 38 68 84
AMLODIPINE BESYLATE-BENAZEPRIL 52 40 68 58
RANITIDINE HCL 50 43 70 80
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 13, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.